NEW YORK: Ernst & Young has unveiled its first global pharmaceutical report, and it points sternly to the need for the industry to position itself positively - and with integrity - in a time of widespread criticism.
The report was delivered by Carolyn Buck Luce, senior partner, health sciences, at the inaugural PRWeek "Pharma's PR Diagnosis" conference in New York last Wednesday.
The presentation addressed four key issues. In reference to "corporate accountability and leadership," Luce said the challenge for PR pros ...